These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

655 related articles for article (PubMed ID: 17549318)

  • 21. Determination of the optimal minimum radioiodine dose in patients with Graves' disease: a clinical outcome study.
    Howarth D; Epstein M; Lan L; Tan P; Booker J
    Eur J Nucl Med; 2001 Oct; 28(10):1489-95. PubMed ID: 11685491
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of methimazole pretreatment on serum thyroid hormone levels after radioactive treatment in Graves' hyperthyroidism.
    Andrade VA; Gross JL; Maia AL
    J Clin Endocrinol Metab; 1999 Nov; 84(11):4012-6. PubMed ID: 10566642
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Graves' disease and radioiodine therapy. Is success of ablation dependent on the achieved dose above 200 Gy?
    Kobe C; Eschner W; Sudbrock F; Weber I; Marx K; Dietlein M; Schicha H
    Nuklearmedizin; 2008; 47(1):13-7. PubMed ID: 18278207
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical study on early changes in thyroid function of hyperthyroidism treated with propylthiouracil and a relatively small dose of iodide.
    Kasai K; Suzuki H; Kikuchi T; Ieiri T; Takemura Y
    Endocrinol Jpn; 1976 Aug; 23(4):347-54. PubMed ID: 1024041
    [TBL] [Abstract][Full Text] [Related]  

  • 25. One-year follow-up of Graves' disease treatment by four different protocols of radioiodine administration.
    Calegaro JU; De Freitas Gomes E; Bae SH; Ulyssea R; Casulari LA
    Panminerva Med; 2000 Dec; 42(4):241-5. PubMed ID: 11294085
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thyroidal triiodothyronine and thyroxine in Graves' disease: correlation with presurgical treatment, thyroid status, and iodine content.
    Larsen PR
    J Clin Endocrinol Metab; 1975 Dec; 41(06):1098-104. PubMed ID: 54364
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Experience with ambulatory radioiodine therapy of hyperthyroidism].
    Róka R; Séra T; Valkusz Z; Julesz J; Csernay L; Pávics L
    Orv Hetil; 1999 Jun; 140(23):1291-5. PubMed ID: 10412264
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term carbimazole intake does not affect success rate of radioactive 131Iodine in treatment of Graves' hyperthyroidism.
    El Refaei SM; Shawkat W
    Nucl Med Commun; 2008 Jul; 29(7):642-8. PubMed ID: 18528187
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Treatment of diffuse hyperthyroid goiter with radioiodine: influence of propylthiouracil pretreatment].
    Véliz J; Pineda G; Arancibia P; Wohllk N
    Rev Med Chil; 2000 Jun; 128(6):609-12. PubMed ID: 11016059
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of methimazole pretreatment on the efficacy of radioactive iodine therapy in Graves' hyperthyroidism: one-year follow-up of a prospective, randomized study.
    Andrade VA; Gross JL; Maia AL
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3488-93. PubMed ID: 11502768
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Evolution of diagnostic and therapeutic criteria in Graves' disease in Spain. Comparison of the results of 2 surveys in 1987 and 1995].
    Escobar Jiménez F; Luna López V; Fernández Soto ML; Quezada Charneco M; Glinoer D
    Med Clin (Barc); 1998 Sep; 111(6):205-10. PubMed ID: 9789225
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Radioiodine therapy and thyrostatic drugs and iodine.
    Moka D; Dietlein M; Schicha H
    Eur J Nucl Med Mol Imaging; 2002 Aug; 29 Suppl 2():S486-91. PubMed ID: 12192550
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Discordant hypothyroxinemia and hypertriiodothyroninemia in treated patients with hyperthyroid Graves' disease and toxic multinodular goiter.
    Gedik O; Ozdemir T; Akalin S
    Isr J Med Sci; 1991 Jul; 27(7):361-4. PubMed ID: 1712765
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Qualitative and quantitative impact of protective glucocorticoid therapy on the effective 131I half-life in radioiodine therapy for Graves disease.
    Hautzel H; Pisar E; Yazdan-Doust N; Schott M; Beu M; Müller HW
    J Nucl Med; 2010 Dec; 51(12):1917-22. PubMed ID: 21078788
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhanced thyroid iodine metabolism in patients with triiodothyronine-predominant Graves' disease.
    Takamatsu J; Hosoya T; Naito N; Yoshimura H; Kohno Y; Tarutani O; Kuma K; Sakane S; Takeda K; Mozai T
    J Clin Endocrinol Metab; 1988 Jan; 66(1):147-52. PubMed ID: 3335601
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Does an individual estimation of halflife improve the results of radioiodine therapy of Graves' disease?
    Schneider P; Körber C; Körber-Hafner N; Hänscheid H; Reiners C
    Nuklearmedizin; 2002 Dec; 41(6):240-4. PubMed ID: 12520660
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Success rate of radioiodine therapy in Graves' disease: the influence of thyrostatic medication.
    Sabri O; Zimny M; Schulz G; Schreckenberger M; Reinartz P; Willmes K; Buell U
    J Clin Endocrinol Metab; 1999 Apr; 84(4):1229-33. PubMed ID: 10199759
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Treatment of hyperthyroidism caused by Graves' disease or toxic multinodular goitre by radioiodine: over 80% cure retrospectively after one calculated dose].
    Bakker SC; Zanin DE; Zweers EJ
    Ned Tijdschr Geneeskd; 2002 Sep; 146(39):1837-41. PubMed ID: 12382370
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Radioactive iodine therapy in Graves' hyperthyroidism.
    Sankar R; Sripathy G
    Natl Med J India; 2000; 13(5):246-51. PubMed ID: 11190053
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discordant hypothyroxinemia and hypertriiodothyroninemia in treated patients with hyperthyroid Graves' disease.
    Chen JJ; Ladenson PW
    J Clin Endocrinol Metab; 1986 Jul; 63(1):102-6. PubMed ID: 2423547
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.